Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2

Enhanced Expression of CXCL10 in Inflammatory Bowel Disease

(2012) Ann E. Østvik et al.   INFLAMMATORY BOWEL DISEASES

Fecal Lipocalin 2, a Sensitive and Broadly Dynamic Non-Invasive Biomarker for Intestinal Inflammation

(2012) Benoit Chassaing et al.   PLoS One

Intestinal antimicrobial peptides during homeostasis, infection, and disease

(2012) Luciana R. Muniz et al.   Frontiers in Immunology

Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity

(2011) K. A. Oikonomou et al.   JOURNAL OF GASTROENTEROLOGY

Intestinal homeostasis and its breakdown in inflammatory bowel disease

(2011) Kevin J. Maloy et al.   NATURE

Activation of REG family proteins in colitis

(2011) Atle Van Beelen Granlund et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Neutrophil Gelatinase-Associated Lipocalin

(2010) Tomas M. Eagan et al.   CHEST

Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy

(2010) L. Landrø et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Rotavirus and coxsackievirus infection activated different profiles of toll-like receptors and chemokines in intestinal epithelial cells

(2009) Jin Xu et al.   INFLAMMATION RESEARCH

Inflammatory Bowel Disease

(2009) Clara Abraham et al.   NEW ENGLAND JOURNAL OF MEDICINE

TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events

(2008) Karen A. Cavassani et al.   JOURNAL OF EXPERIMENTAL MEDICINE